BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3916488)

  • 1. The lymphocyte subpopulations in cyclosporine-treated human heart rejection.
    Weintraub D; Masek M; Billingham ME
    J Heart Transplant; 1985 Feb; 4(2):213-6. PubMed ID: 3916488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
    Imakita M; Tazelaar HD; Billingham ME
    J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cellular rejection and cyclosporine nephrotoxicity monitored by biopsy in a renal allograft recipient. The differentiation of drug nephrotoxicity from rejection by phenotyping of cellular infiltrates.
    Kolbeck PC; Scheinman JI; Sanfilippo F
    Arch Pathol Lab Med; 1986 May; 110(5):389-93. PubMed ID: 3516116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propagation and characterization of lymphocytes from rejecting human cardiac allografts.
    Carlquist JF; Hammond EH; Anderson JL
    J Heart Transplant; 1988; 7(6):397-406. PubMed ID: 3062146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical allogeneic heart transplant rejection: correlations between histology and immune reactivity detected by cytokine messenger RNA.
    Normann SJ; Peck AB; Staples ED; Salomon DR; Mills RM
    J Heart Lung Transplant; 1996 Aug; 15(8):778-89. PubMed ID: 8878760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients.
    Herskowitz A; Soule LM; Ueda K; Tamura F; Baumgartner WA; Borkon AM; Reitz BA; Achuff SC; Traill TA; Baughman KL
    J Heart Transplant; 1987; 6(3):127-36. PubMed ID: 3309214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies to quantitate T lymphocyte subpopulations in human cardiac allografts.
    Rose ML; Gracie JA; Fraser A; Chisholm PM; Yacoub MH
    Transplantation; 1984 Sep; 38(3):230-4. PubMed ID: 6382712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endomyocardial biopsy in the heart transplant patient: the state of the art].
    Arbustini E; Grasso M; Diegoli M; Gavazzi A; Campana C; Martinelli L; Goggi C; Pucci A; Grossi P; Ippoliti G
    G Ital Cardiol; 1991 Oct; 21(10):1107-23. PubMed ID: 1804749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Relevance for clinical cardiac graft rejection.
    Vaessen LM; Baan CC; Ouwehand AJ; Balk AH; Jutte NH; Mochtar B; Claas FH; Weimar W
    Transplantation; 1994 Apr; 57(7):1051-9. PubMed ID: 8165702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The coronary sinus as a source of activated T-lymphocytes in patients after orthotopic heart transplantation].
    Holzinger C; Zuckermann A; Schöllhammer A; Kopp C; Imhof M; Laufer G; Griesmacher A; Zwölfer W; Laczkovics A; Wolner E
    Wien Klin Wochenschr; 1992; 104(24):748-52. PubMed ID: 1288018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential endocardial residence of B-cells in the "Quilty effect" of human heart allografts: immunohistochemical distinction from rejection.
    Radio SJ; McManus BM; Winters GL; Kendall TJ; Wilson JE; Costanzo-Nordin MR; Ye YL
    Mod Pathol; 1991 Sep; 4(5):654-60. PubMed ID: 1836878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune monitoring of blood in heart transplant recipients: application of flow cytometry.
    Garner RJ; Springgate C; Hoyt T
    Semin Diagn Pathol; 1989 Feb; 6(1):83-90. PubMed ID: 2645626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporine on the transplanted human heart.
    Stovin PG; English TA
    J Heart Transplant; 1987; 6(3):180-5. PubMed ID: 3309222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study.
    Arbustini E; Grasso M; Diegoli M; Bramerio M; Foglieni AS; Albertario M; Martinelli L; Gavazzi A; Goggi C; Campana C
    Am J Pathol; 1991 Oct; 139(4):709-15. PubMed ID: 1928295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
    Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
    Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.